In clinical trials, people adding BENLYSTA to their treatment plan decreased their risk of severe flares in the first year of use. Results may vary. ‡Compared to other lupus medications alone.§A reduction of steroid dose was seen but was not statistically significant. ...
More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.KLATZMANN, DAVIDSAADOUN, DAVIDCACOUB, PATRICEROSENZWAJG, MICHLEPIAGGIO, ELIANE...
aYou need to find out what works best for you. You may find that a rheumatologist has the best treatment plan for you. Other health professionals who can help you deal with different aspects of lupus include 您需要发现什么为您最好运作。 您可以发现关节炎医师有最佳的治疗计划为您。 可帮助您应...
Maternal mortality, which is 20-fold higher among lupus patients [19], is essentially related to the activity of the patient's SLE, onset of pre-eclampsia, the existence of antiphospholipid antibodies and the adverse effects of treatment, particularly infectious events [15,19,20]. Fetal and ...
Figure 3. Measures to minimize the risk of complications related to lupus nephritis or its treatment. Note: Chapter 1 refers to Chapter 1 of the KDIGO Guideline on Glomerular Diseases. AKI, acute kidney injury; CKD, chronic kidney disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HI...
The important point of our case is the choice of the treatment plan because many variables should be considered to gain the optimal result. In terms of CLI, limb saving, as the goal, can be achieved by either endovascular therapy (EVT) or bypass graft method depending on the main lesion....
When SLE flares occur during pregnancy, it is essential to develop an individualized treatment plan that considers disease activity, affected organs, and the extent of organ damage. For patients with mild disease activity, we recommend the use of low-dose fluorine-free glucocorticoids (equivalent to...
5. Kanodia VK, Vanikar AV, Goplani KR, Gupta SB, Trivedi HL: Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report. Diagn Pathol 2008, 28:9. 6. Oqunbiyi AO, Geoge AO, Brown O, Okafor BO: Diagnostic and treatment difficulties in systemic lupus erythematosus ...
Considerable progress has been made in our understanding of the pathogenesis of SLE but the mainstay of therapy has, for the past fifty years or so, been hydroxychloroquine, corticosteroids and immunosuppressants [2]. Biological therapies have been used successfully in the treatment of rheu...
Without proper treatment, patients can eventually die of renal failure. To date, no therapy for SLE has been satisfactory. The current standard of care for SLE patients mainly relies on corticosteroids, which essentially induce systemic immunosuppression to control the disease. However, the use of ...